Thermo Fisher Scientific Inc. / Fundamentals
Income statement
- Net revenue
€37.08B - Cost of goods sold
€21.60B - Gross profit
€15.48B - SG&A expenses
€6.59B - R&D expenses
€1.21B - EBITDA
€6.48B - D&A
€1.27B - EBIT
€6.35B - Interest expenses
-€29.17M - EBT
€6.02B - Tax expenses
€53.20M - Net income
€5.65B
Cash flow statement
- Net deferred tax
-€858.86M - Non-cash items
-€1.35B - Changes in working capital
€535.39M - Operating cash flow
€6.50B - Capex
€1.21B - Other investing cash flow
€560.27M - Net investing cash flow
-€3.75B - Total cash dividends paid
-€523.38M - Issuance of common stock
€0.00 - Debt repayment
-€3.09B - Other financing cash flow
-€628.06M - Net financing cash flow
-€5.10B - Foreign exchange effects
€214.50M - Net change in cash
-€2.13B - Cash at end of period
€3.95B - Free cash flow
€7.71B
Balance sheet
- Cash and cash equivalents
€3.93B - Cash and short-term investments
€5.48B - Total receivables
€7.37B - Inventory
€4.77B - Other current assets
€3.47B - Total current assets
€21.09B - Property, plant & equipment
€8.27B - Goodwill
€40.54B - Intangible assets
€13.00B - Long-term investments
€0.00 - Other non-current assets
€3.96B - Total non-current assets
€65.76B - Total assets
€86.86B - Accounts payable
€0.00 - Short-term debt
€1.90B - Other current liabilities
€9.01B - Total current liabilities
€10.91B - Long-term debt
€28.33B - Deferred tax liabilities
€0.00 - Other non-current liabilities
€4.31B - Total non-current liabilities
€32.63B - Total liabilities
€43.55B - Common stock
€0.00 - Retained earnings
€0.00 - Other equity
€0.00 - Total equity
€0.00 - Total liabilities and shareholders' equity
€86.86B
Company information
- Market capitalization
€131.46B - Employees
125K - Enterprise Value
€186.77B
Company ratios
- Gross margin
-
41.7% Worse than peer group: 50.4% - EBITDA margin
-
17.5% Much better than peer group: -42.5% - EBIT margin
-
17.1% Much better than peer group: -54.1% - EBT margin
-
16.2% Much better than peer group: -36.2% - Net margin
-
15.2% Much better than peer group: -56.8% - ROE
-
0.0% - ROA
-
6.5% Even with peer group: 4.0% - Asset turnover
-
42.7% Much worse than peer group: 73.9% - FCF margin
-
14.3% Much better than peer group: -40.3% - FCF yield
4.0% - Efficiency ratio
82.5% - Net sales per employee
-
€296.61K - Net income per employee
-
€45.19K